全文获取类型
收费全文 | 19287篇 |
免费 | 1492篇 |
国内免费 | 1073篇 |
出版年
2024年 | 32篇 |
2023年 | 205篇 |
2022年 | 510篇 |
2021年 | 903篇 |
2020年 | 601篇 |
2019年 | 738篇 |
2018年 | 827篇 |
2017年 | 550篇 |
2016年 | 849篇 |
2015年 | 1153篇 |
2014年 | 1308篇 |
2013年 | 1466篇 |
2012年 | 1767篇 |
2011年 | 1555篇 |
2010年 | 964篇 |
2009年 | 847篇 |
2008年 | 1068篇 |
2007年 | 933篇 |
2006年 | 822篇 |
2005年 | 731篇 |
2004年 | 585篇 |
2003年 | 549篇 |
2002年 | 472篇 |
2001年 | 358篇 |
2000年 | 295篇 |
1999年 | 288篇 |
1998年 | 180篇 |
1997年 | 137篇 |
1996年 | 105篇 |
1995年 | 111篇 |
1994年 | 78篇 |
1993年 | 70篇 |
1992年 | 97篇 |
1991年 | 96篇 |
1990年 | 87篇 |
1989年 | 68篇 |
1988年 | 56篇 |
1987年 | 53篇 |
1986年 | 39篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 19篇 |
1976年 | 15篇 |
1975年 | 14篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
781.
SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel,CNS penetrant tricyclic M4 PAMs
Trevor C. Chopko Changho Han Alison R. Gregro Darren W. Engers Andrew S. Felts Mike S. Poslusney Katrina A. Bollinger Ryan D. Morrison Michael Bubser Atin Lamsal Vincent B. Luscombe Hyekyung P. Cho Nathalie C. Schnetz-Boutaud Alice L. Rodriguez Sichen Chang J. Scott Daniels Donald F. Stec Colleen M. Niswender Bruce J. Melancon 《Bioorganic & medicinal chemistry letters》2019,29(16):2224-2228
This letter describes progress towards an M4 PAM preclinical candidate inspired by an unexpected aldehyde oxidase (AO) metabolite of a novel, CNS penetrant thieno[2,3-c]pyridine core to an equipotent, non-CNS penetrant thieno[2,3-c]pyrdin-7(6H)-one core. Medicinal chemistry design efforts yielded two novel tricyclic cores that enhanced M4 PAM potency, regained CNS penetration, displayed favorable DMPK properties and afforded robust in vivo efficacy in reversing amphetamine-induced hyperlocomotion in rats. 相似文献
782.
783.
784.
Fan Wu Chuan Ma Bin Han Lifeng Meng Han Hu Yu Fang Mao Feng Xufeng Zhang Olav Rueppell Jianke Li 《Molecular ecology》2019,28(18):4212-4227
Reproductive investment is a central life history variable that influences all aspects of life. Hormones coordinate reproduction in multicellular organisms, but the mechanisms controlling the collective reproductive investment of social insects are largely unexplored. One important aspect of honey bee (Apis mellifera) reproductive investment consists of raising female‐destined larvae into new queens by alloparental care of nurse bees in form of royal jelly provisioning. Artificial selection for commercial royal jelly production over 40 years has increased this reproductive investment by an order of magnitude. In a cross‐fostering experiment, we establish that this shift in social phenotype is caused by nurse bees. We find no evidence for changes in larval signalling. Instead, the antennae of the nurse bees of the selected stock are more responsive to brood pheromones than control bees. Correspondingly, the selected royal jelly bee nurses are more attracted to brood pheromones than unselected control nurses. Comparative proteomics of the antennae from the selected and unselected stocks indicate putative molecular mechanisms, primarily changes in chemosensation and energy metabolism. We report expression differences of several candidate genes that correlate with the differences in reproductive investment. The functional relevance of these genes is supported by demonstrating that the corresponding proteins can competitively bind one previously described and one newly discovered brood pheromone. Thus, we suggest several chemosensory genes, most prominently OBP16 and CSP4, as candidate mechanisms controlling queen rearing, a key reproductive investment, in honey bees. These findings reveal novel aspects of pheromonal communication in honey bees and explain how sensory changes affect communication and lead to a drastic shift in colony‐level resource allocation to sexual reproduction. Thus, pheromonal and hormonal communication may play similar roles for reproductive investment in superorganisms and multicellular organisms, respectively. 相似文献
785.
786.
787.
Leyao Li Lingling Wu Xia E Wenru Yan Xingguang Cai Jing Han Lidan Sun 《Bioorganic & medicinal chemistry》2019,27(8):1670-1676
Glucagon-like peptide-1 (GLP-1) has emerged as a major therapeutic target for the treatment of type 2 diabetes. The nonapeptide GLP-1 (28–36) amide is one of the biological C-terminal products of GLP-1 modified by the neutral endopeptidase (NEP) 24.11 with limited hypoglycemic activity. In this study, we focused on the modification of GLP-1 (28–36) amide for the first time and synthesized a series of GLP-1 (28–36) amide analogues. Results of biological activity evaluation in INS-1 cell, STZ-induced diabetic and diet induced obesity (DIO) mice indicated that S3 as a promising candidate to treat type 2 diabetes and obesity. 相似文献
788.
789.
790.
Xia Kai Bao Han Zhang Fuming Linhardt Robert J. Liang Xinle 《Journal of industrial microbiology & biotechnology》2019,46(6):869-882
Journal of Industrial Microbiology & Biotechnology - Bacterial toxin–antitoxin (TA) systems play important roles in diverse cellular regulatory processes. Here, we characterize three... 相似文献